More articles from PERSPECTIVES IN PHARMACOLOGY

You have access
Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels
Arun Anantharam, Steven M. Markowitz and Geoffrey W. Abbott

Journal of Pharmacology and Experimental Therapeutics December 2003, 307 (3) 831-838; DOI: https://doi.org/10.1124/jpet.103.054569
You have access
Steroid Hormone Interactions with Target Cells: Cross Talk between Membrane and Nuclear Pathways
Mary C. Farach-Carson and Paul J. Davis

Journal of Pharmacology and Experimental Therapeutics December 2003, 307 (3) 839-845; DOI: https://doi.org/10.1124/jpet.103.055038
You have access
Protease-Activated Receptors: New Concepts in Regulation of G Protein-Coupled Receptor Signaling and Trafficking
Joann Trejo

Journal of Pharmacology and Experimental Therapeutics November 2003, 307 (2) 437-442; DOI: https://doi.org/10.1124/jpet.103.052100
You have access
Inflammation and Drug Idiosyncrasy—Is There a Connection?
Robert A. Roth, James P. Luyendyk, Jane F. Maddox and Patricia E. Ganey

Journal of Pharmacology and Experimental Therapeutics October 2003, 307 (1) 1-8; DOI: https://doi.org/10.1124/jpet.102.041624
You have access
The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development
A. V. Terry and J. J. Buccafusco

Journal of Pharmacology and Experimental Therapeutics September 2003, 306 (3) 821-827; DOI: https://doi.org/10.1124/jpet.102.041616
You have access
Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?
Hanns Ulrich Zeilhofer and Girolamo Calò

Journal of Pharmacology and Experimental Therapeutics August 2003, 306 (2) 423-429; DOI: https://doi.org/10.1124/jpet.102.046979
You have access
Ontogenesis of β-Adrenoceptor Signaling: Implications for Perinatal Physiology and for Fetal Effects of Tocolytic Drugs
Theodore A. Slotkin, J. Todd Auman and Frederic J. Seidler

Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 1-7; DOI: https://doi.org/10.1124/jpet.102.048421
You have access
Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans
David S. Goldstein, Graeme Eisenhofer and Irwin J. Kopin

Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 800-811; DOI: https://doi.org/10.1124/jpet.103.049270
You have access
Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile?
Lawrence H. Lash, Ronald N. Hines, Frank J. Gonzalez, Timothy R. Zacharewski and Mark A. Rothstein

Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 403-409; DOI: https://doi.org/10.1124/jpet.102.039925
You have access
The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics
Keith A. Gary, Kevin A. Sevarino, George G. Yarbrough, Arthur J. Prange and Andrew Winokur

Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 410-416; DOI: https://doi.org/10.1124/jpet.102.044040

Main menu

User menu

Search

More articles from PERSPECTIVES IN PHARMACOLOGY

Pages

Navigate

More Information

ASPET's Other Journals